Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000806512 | SCV000946516 | uncertain significance | Hereditary spastic paraplegia 49 | 2022-10-04 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 777 of the TECPR2 protein (p.Ser777Asn). This variant is present in population databases (rs144849839, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with TECPR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 651200). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000995260 | SCV001149347 | uncertain significance | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | TECPR2: PM2:Supporting, BP4 |
Baylor Genetics | RCV000806512 | SCV001528890 | uncertain significance | Hereditary spastic paraplegia 49 | 2018-12-24 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000995260 | SCV001874821 | uncertain significance | not provided | 2021-07-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26542466) |
Genome Diagnostics Laboratory, |
RCV001849110 | SCV002105926 | uncertain significance | Hereditary spastic paraplegia | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000806512 | SCV001461379 | uncertain significance | Hereditary spastic paraplegia 49 | 2020-04-17 | no assertion criteria provided | clinical testing |